| Patent Number |
Title Of Patent |
Date Issued |
| 7691371 |
Preparation comprising batroxobin for inhibiting local invasion of malignant tumors |
April 6, 2010 |
| A preparation for inhibiting local invasion of malignant tumors is provided which comprises batroxobin and therefore can inhibit local invasion of malignant tumors. A preparation for encapsulating malignant tumor tissues is also provided which comprises batroxobin and therefore can c |
| 6399576 |
Method of inhibiting apoptosis |
June 4, 2002 |
| A method of inhibiting apoptosis, comprising administering an effective ingredient batroxobin. |
| 6106830 |
Methods for the treatment of apoptosis-related diseases by batroxobin |
August 22, 2000 |
| A pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases which comprises as an effective ingredient batroxobin. |
| 5869044 |
Method for the treatment or prophylaxis of ischemia-reperfusion injury |
February 9, 1999 |
| Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury in myocardial ischemia and cerebral ischemia, characterized in that the medicament contains batroxobin as an effective component. |
| 5716958 |
Amino acid derivative having anti-CCK activity |
February 10, 1998 |
| A compound represented by the formula (1): ##STR1## wherein, m is an integer of 1 to 3;n is an integer 0 or 1;A represents CH or N atom, and forms together with the N atom bonded to the carbonyl group a piperidine ring or a piperazine ring;R.sub.1 independently represents a straight or b |
| 5595974 |
Medicaments for the treatment of restenosis and arterial sclerosis |
January 21, 1997 |
| A medicament for the treatment and/or prophylaxis of restenosis and arterial sclerosis after percutaneous transluminal angioplasty, characterized in that the medicament contains batroxobin as an effective component. |
| 4725578 |
Compounds having therapeutic effect and the preparation thereof |
February 16, 1988 |
| New compounds of the following general formula: ##STR1## wherein R.sub.1 is acyl, alkyl, cycloalkyl, carboxyalkyl or ester thereof, heterocyclic group, saccharide residue or hydrogen atom, R.sub.2 stands for hydrogen atom or a lower alkyl and R.sub.3 represents hydrogen atom or a |
| 4476299 |
Cyclic polyamino containing compounds having therapeutic effect and the preparation thereof |
October 9, 1984 |
| New compounds of the following general formula: ##STR1## wherein R.sub.1 is acyl, alkyl, cycloalkyl, carboxyalkyl or ester thereof, heterocyclic group, saccharide residue or hydrogen atom, R.sub.2 stands for hydrogen atom or a lower alkyl and R.sub.3 represents hydrogen atom or a |
| 4265881 |
Plasminogen-activating substance and the preparation and use of such substance |
May 5, 1981 |
| A new type of plasminogen-activating substance is extracted from the bile of hogs, which substance is characterized by;(A) a molecular weight of 80,000 .+-.10,000;(B) an isoelectric point of 7.1;(C) an ultraviolet absorption spectrum showing a peak (.lambda. max) at a wave length of about 27 |
| 4159321 |
Agent for inhibiting tumor induced by leukemia virus |
June 26, 1979 |
| A process for preparing an antimalignant agent which comprises cultivating Staphylococcus epidermidis STF (Bikoken(or Microbic Industry Technological Institute)Deposit No. 3706; ATCC 31310) in a liquid culture medium, removing solid matter from the culture solution, concentrating the |
